Evidence map›Paper›PMID 12569400›Full record

ArticlePlanta2003

MSI-99, a magainin analogue, imparts enhanced disease resistance in transgenic tobacco and banana.

A Chakrabarti, T R Ganapathi, P K Mukherjee, V A Bapat

Abstract read
PubMed Publisher
In one paragraph

Article in Planta, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 172 citations in OpenAlex.

  1. Banana breeding by genome design.Journal of integrative plant biology · 2025
    Review
  2. Article
  3. Review
  4. Engineering a marine microalga Chlorella sp. as the cell factory.Biotechnology for biofuels and bioproducts · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Extremophilic proteases as novel and efficient tools in short peptide synthesis.Journal of industrial microbiology & biotechnology · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A ChakrabartiNuclear Agriculture and Biotechnology DivisionBhabha Atomic Research Centre, 400085, Trombay, Mumbai, India.
T R Ganapathi
P K Mukherjee
V A Bapat
Bhabha Atomic Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magainin is one of the earliest reported antimicrobial peptides isolated from skin secretions of the African clawed frog Xenopus laevis. A synthetic substitution analogue of magainin, MSI-99, is employed in this study to impart disease resistance in transgenic tobacco ( Nicotiana tabacumL.) and banana [( Musaspp. cv. Rasthali (AAB)]. This peptide inhibited the growth and spore germination of Fusarium oxysporumf.sp. cubenseat 16 micro g/ml. MSI-99 has been subcloned into plant expression vectors pMSI164 and pMSI168, targeting the peptide into the cytoplasm and extracellular spaces, respectively. Tobacco plants transformed with pMSI168 showed enhanced resistance against Sclerotinia sclerotiorum, Alternaria alternataand Botrytis cinerea. Transgenic banana pants were obtained for both pMSI164 and pMSI168 transformations and showed resistance to F. oxysporumf.sp. cubenseand Mycosphaerella musicola. The transgenic nature of the transformants and expression of this peptide was confirmed through polymerase chain reaction (PCR) and reverse transcription (RT)-PCR. The results suggest that MSI-99 can be useful in imparting enhanced disease resistance in transgenic plants.

Indexed as

AlternariaAmino Acid SequenceAntifungal AgentsAscomycotaBotrytisCloning, MolecularFungiFusariumGene Expression Regulation, PlantImmunity, InnateMolecular Sequence DataMusaNicotianaPeptidesPlant DiseasesPlant ProteinsAntifungal AgentsMSI-99 peptidePeptidesPlant ProteinsRecombinant Proteins

Identifiers

PMID12569400
OpenAlexW1527748238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.